Huddersfield company Paxman launches system to reduce chemotherapy-related nerve damage
Huddersfield-based Paxman has developed a new device designed to prevent chemotherapy-induced peripheral neuropathy, a condition that can cause long-term pain and numbness for patients. By expanding beyond their established scalp cooling technology, the company aims to provide a new option for managing treatment side effects that currently have few preventative solutions.
Source: Yorkshire Post
West Yorkshire
Read the full story